Smart drugs to fight cancer
OpenProtein.AI expands partnership with Boehringer Ingelheim on AI-driven antibody discovery
New biomarker helps assess aggression of glioblastoma
Protein helps cancer cells survive treatment
Orphan Drug Designation for cholangiocarcinoma treatment
Yeast cells can be used for rapid testing of cancer immunotherapy
Pfizer injectable shows continued weight loss in phase 2b trial
Skin damage protein ID could lead to new therapies
Origami Therapeutics and Ipsen to advance protein degrader programme
IQVIA and Boehringer Ingelheim announce data collaboration
Next-generation biopreservation for cell therapy
Predicting cancer evolution